End points for predicting coronary risk must be clarified [2]

British Medical Journal

Volumn 323, Issue 7309, 2001, Pages 396-397

  Lampe, F C ^a   Walker, M ^a   Shaper, A G ^a   Brindle, P M ^a   Whincup, P H ^a   Ebrahim, S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CORONARY RISK; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 0035908758     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Joint British recommendations on prevention of coronary heart disease in clinical practice
2. Cardiovascular disease risk profiles
3. Cardiovascular risk factors and their effects on the decision to treat hypertension: Evidence based review
4. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men